0.37
+2.82%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Diagnos
Its shares trade on TSX Venture under the ticker ADK.V. It has been listed since 27 September 2000. In the fiscal year to 31 March 2026, it reported revenue of C$65,478 and a net loss of C$4.6m. At that date it held total assets of C$2.4m and shareholders' equity of C$686,897.
Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. Its geographical areas include Canada, the United States, Saudi Arabia, Mexico, Costa Rica and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 27 Sept 2000
- Website
- diagnos.com ↗
Leadership
Pay as last reported
- Mr. Andre LarentePresident, Director, since 2000C$254,000
- Mr. Marc-andre MassueChief Financial Officer, Company SecretaryC$144,100
- Mr. Yves-Stephane CoutureChief Operating Officer
- Mr. Philippe CouillardDirector
- Mr. Michael BraeuelIndependent Director
- Mr. Robert DunnIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Diagnos Inc's CARA provides real-time retinal image analysis for large patient volumes in Canada and the US.
- FLAIRE enables application development for healthcare AI solutions across multiple countries including Saudi Arabia.
- Diagnos Healthcare (India) Private Limited supports global healthcare AI services in the Indian market.
Weaknesses
- Diagnos International SA de CV operates in Mexico and Costa Rica with limited market penetration.
- The company's IPO in 2000 may limit access to recent capital markets for expansion.
- Brossard, Quebec headquarters may restrict international business development opportunities.
Opportunities
- Expanding CARA to Chile and Saudi Arabia could increase healthcare AI adoption in emerging markets.
- Growing demand for AI in Health Care sector presents opportunities for Diagnos Inc's services.
- Collaborating with Diagnos Healthcare (India) Private Limited could enhance global market reach.
Threats
- Competition from other Health Care AI providers in the US and Canada may reduce market share.
- Regulatory changes in Saudi Arabia could impact Diagnos Inc's operations in that region.
- Economic instability in Mexico might affect Diagnos International SA de CV's performance.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.